Biotech Startups

Mumilk develops lab-grown human milk by recreating the function of mammary glands in vitro, aiming to produce nutrition containing bioactive molecules found in breast milk. The product is intended as an alternative for parents when breastfeeding is not an option.

1 investor

Mussel Polymers develops bio-inspired adhesive solutions based on mussel-derived chemistry for underwater, high-moisture, and specialized industrial applications including medical, military, and marine restoration. The company produces a patented polymer adhesive system that is nontoxic, environmentally friendly, and significantly stronger than conventional commercial alternatives.

1 investor

Mustang Bio in-licenses and develops next-generation therapies aimed at treating patients, operating in the biotechnology and therapeutics sector.

1 investor

MVM is a healthcare-focused investment firm that provides growth equity to companies in medical technology, pharmaceuticals, diagnostics, digital health, life science tools, and contract research and manufacturing. Operating from Boston and London since 1997, it partners with management teams to scale differentiated healthcare products across global markets.

1 investor

MVT in Silico develops computational platforms and simulation tools for drug discovery and biomedical research, enabling researchers to predict therapeutic effects and optimize drug development. The company serves pharmaceutical and biotechnology firms seeking to reduce late-stage development failures through model-informed drug development and in silico modeling.

1 investor

MVT Pharma develops ultrasound contrast agents and theranostics to advance imaging and treatment capabilities. The company focuses on drug discovery and development in medical imaging and oncology.

1 investor

My Gene Counsel offers a suite of digital genetic counseling and risk assessment tools, including its Living Lab Reports, that deliver continuously updated genomic insights to patients and providers. It serves biotech, hospitals and health systems, and pharmaceutical/research partners across the precision medicine care pathway.

1 investor

MYCEL develops mycelium-based bio-materials and a platform for producing high-performance, biodegradable materials integrated into circular systems. It targets regenerative industries, offering fully bio-based materials and converting residual biomass into inputs for soil and cosmetic applications.

1 investor

Muse Bio produces a naturally derived, cell-free skincare ingredient from renewable biological resources and directs net proceeds to fund women's health research.

1 investor

MycoFoundry develops mycelium-based materials for architectural and interior applications, combining biotechnology and design. The company produces acoustic panels, furniture, and custom biofabricated materials for the built environment.

1 investor

Mycosortia produces climate-resilient cocoa alternatives using proprietary microbial consortia and an AI-driven biotransformation process (AuroGenesis) to mimic regional cocoa flavor profiles. It targets global food manufacturers seeking a consistent, price-stable substitute for traditional cocoa.

1 investor

CREATE Medicines develops in vivo CAR immunotherapy using proprietary mRNA-LNP technology to program T cells, NK cells, and myeloid cells directly within the body for cancer, autoimmunity, and fibrosis. The company's multi-immune platform enables off-the-shelf therapies with repeat dosing capability.

1 investor

MyImmune develops AI that analyzes adaptive immune repertoire data to identify drug targets, predict patient responses to immunotherapies, and build biomarkers and companion diagnostics. It serves biotech, pharma, and CRO customers working in oncology, autoimmune, and infectious diseases.

1 investor

Mykito Sciences manufactures vegan, non-animal chitosan for medical, pharmaceutical, food, and industrial applications using advanced analytical facilities and GMP quality systems. The company achieves over 85% reduction in CO2 emissions compared to industry standards through its plant-based production methods.

1 investor

myNEO provides AI-powered software for drug discovery and development, specifically targeting antibody, bispecific, ADC, cell therapy, vaccine, and neoantigen-based immunotherapy programs. The company serves pharmaceutical and biotech organizations across target discovery, optimization, and data analysis stages.

1 investor

Myodenovo cultivates lab-grown meat, using scaffolds and bioreactors to produce premium cuts such as filet mignon without slaughtering animals. It targets meat consumers seeking high-quality, sustainable cultivated meat products.

1 investor

Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.

1 investor

Myoworks Private Limited develops ancillary input products, primarily edible scaffolds that give cultivated meat its shape, structure, texture and taste, for companies producing cultivated (lab-grown) meat. The company positions its products within the cultivated meat industry with a focus on sustainability and animal welfare.

1 investor

Myriad Genetics is a genetic testing and precision medicine company that delivers molecular diagnostic test results across hereditary cancer risk, reproductive health, oncology, urology, and mental health. It serves patients and healthcare providers with insights to help detect, treat, and prevent disease.

1 investor

MyRNA offers cancer risk screening, positioning it as part of broader healthcare and care conversations. The company participates in healthcare industry events in Malaysia, including the Selangor International Care Expo.

1 investor

Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.

1 investor

Provides microbial genetic analysis services, including metagenomic analysis and measurement of microbial DNA copy numbers from samples, for companies conducting product evaluation and research and development. Supplies a proprietary microbiome sampling kit to help clients capture microbial flora for personalized product development.

1 investor

1 investor

Newform Foods is a South African food technology company specializing in food and biotech research, operating the Newform Applied Biotech Centre at South Ormsby Estate in Lincolnshire.

1 investor